Clinical Trial

Impact of Discontinuing GLP-1 Receptor Agonists for Two Weeks Prior to Upper Endoscopy on the Risk of Gastric Retention

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 11, 2025 (before its estimated December 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
A retrospective observational study to explore the impact of discontinuing GLP-1 receptor agonists for two weeks prior to upper endoscopy on the risk of gastric retention
Trial Details
NCT Number NCT07276763
Lead Sponsor Fudan University
Conditions Gastric Retention
Enrollment 16,509 participants
Start Date 2025-12-10
Primary Completion 2025-12-15 (estimated)
Study Completion 2025-12-15 (estimated)
Updated on ClinicalTrials.gov 2025-12-11